Recursion Pharmaceuticals Inc Clas (RXRX)
Income Before Tax
-$131.01M
Quarterly · Period ending: · USD
RXRX Income Before Tax
Latest reported-$131.01Mperiod ending
Latest reported-$131.01Mperiod ending
RXRX Quarterly Pre-Tax Income (-$18.42M → -$131.01M)
Quarterly income before tax
High-resolution chart · PNG
RXRX income before tax history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Before Tax (USD) |
|---|---|
| -131,006,000 | |
| -122,108,000 | |
| -108,102,000 | |
| -162,250,000 | |
| -171,897,000 | |
| -202,645,000 | |
| -178,899,000 | |
| -95,675,000 | |
| -98,063,000 | |
| -92,152,000 | |
| -97,058,000 | |
| -93,017,000 | |
| -76,727,000 | |
| -65,327,000 | |
| -57,492,000 | |
| -60,445,000 | |
| -65,560,000 | |
| -55,979,000 | |
| -64,933,000 | |
| -47,428,000 | |
| -43,401,000 | |
| -30,717,000 | |
| -25,766,000 | |
| -23,873,000 | |
| -18,943,000 | |
| -18,424,000 |